Temat: "Cannabinoid receptor" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Molecular basis for ligand modulation of the cannabinoid CB 1 receptor.
Autorzy:: Ramesh K; Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Rosenbaum DM; Department of Biophysics, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2022 Jul; Vol. 179 (14), pp. 3487-3495. Date of Electronic Publication: 2021 Aug 12.
Typ publikacji:: Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:: Cannabinoid Receptor Agonists*
Cannabinoids*
Endocannabinoids/metabolism ; Ligands ; Receptor, Cannabinoid, CB1 ; Receptor, Cannabinoid, CB2 ; Receptors, Cannabinoid/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice.
Autorzy:: Myers AM; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Siegele PB; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Foss JD; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Tuma RF; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.
Ward SJ; Center for Substance Abuse Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, USA.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 May; Vol. 176 (10), pp. 1552-1567. Date of Electronic Publication: 2018 Mar 01.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Cannabidiol/*pharmacology
Cannabinoid Receptor Agonists/*adverse effects
Cannabis/*chemistry
Cognition/*drug effects
Dronabinol/*adverse effects
Substance Withdrawal Syndrome/*prevention & control
Animals ; Cannabidiol/administration & dosage ; Cannabidiol/isolation & purification ; Cannabinoid Receptor Agonists/administration & dosage ; Cannabinoid Receptor Agonists/chemical synthesis ; Cannabinoid Receptor Antagonists/pharmacology ; Dronabinol/administration & dosage ; Dronabinol/chemical synthesis ; Mice ; Mice, Inbred C57BL ; Receptor, Cannabinoid, CB1/agonists ; Receptor, Cannabinoid, CB1/antagonists & inhibitors ; Receptor, Cannabinoid, CB2/agonists ; Substance Withdrawal Syndrome/etiology ; Substance Withdrawal Syndrome/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Preclinical evaluation of [ F]MA3: a CB 2 receptor agonist radiotracer for PET.
Autorzy:: Attili B; Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Celen S; Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Ahamed M; Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Koole M; Department of Nuclear Medicine and Molecular Imaging, UZ Gasthuisberg, Leuven, Belgium.
Haute CVD; Laboratory for Neurobiology and Gene Therapy, Department of Neurosciences, KU Leuven, Leuven, Belgium.; Leuven Viral Vector Core, Molecular Medicine, KU Leuven, Leuven, Belgium.
Vanduffel W; Laboratory for Neuro- and Psychophysiology, Department of Neurosciences, KU Leuven, Leuven, Belgium.
Bormans G; Radiopharmaceutical Research, Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 May; Vol. 176 (10), pp. 1481-1491. Date of Electronic Publication: 2019 Jan 30.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Radiopharmaceuticals*
Cannabinoid Receptor Agonists/*metabolism
Positron-Emission Tomography/*methods
Quinolines/*metabolism
Receptor, Cannabinoid, CB2/*metabolism
Animals ; Autoradiography/methods ; Brain/diagnostic imaging ; Brain/metabolism ; Cannabinoid Receptor Agonists/blood ; Cannabinoid Receptor Agonists/chemical synthesis ; Drug Evaluation, Preclinical ; Macaca mulatta ; Protein Binding ; Quinolines/chemical synthesis ; Rats ; Receptor, Cannabinoid, CB2/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Model-free and kinetic modelling approaches for characterising non-equilibrium pharmacological pathway activity: Internalisation of cannabinoid CB 1 receptors.
Autorzy:: Zhu X; Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand.
Finlay DB; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand.; Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Glass M; Department of Pharmacology and Toxicology, University of Otago, Dunedin, New Zealand.; Department of Pharmacology and Clinical Pharmacology, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Duffull SB; Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Jul; Vol. 176 (14), pp. 2593-2607. Date of Electronic Publication: 2019 May 21.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Models, Biological*
Cannabinoid Receptor Agonists/*pharmacology
Receptor, Cannabinoid, CB1/*agonists
Cannabinoid Receptor Agonists/chemistry ; Cells, Cultured ; Humans ; Kinetics ; Receptor, Cannabinoid, CB1/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
Autorzy:: McIntosh BT; Department of Pharmacology and Laboratory for Retina and Optic Nerve Research, Dalhousie University, Halifax, Nova Scotia, Canada.
Hudson B
Yegorova S
Jollimore CA
Kelly ME; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2007 Dec; Vol. 152 (7), pp. 1111-20. Date of Electronic Publication: 2007 Oct 08.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cannabinoid Receptor Agonists*
Benzoxazines/*pharmacology
Morpholines/*pharmacology
Naphthalenes/*pharmacology
Signal Transduction/*physiology
Trabecular Meshwork/*physiology
Arachidonic Acids/pharmacology ; Benzoxazines/antagonists & inhibitors ; Blotting, Western ; Calcium Signaling/drug effects ; Calcium Signaling/physiology ; Cannabinoid Receptor Antagonists ; Cell Line ; Cells, Cultured ; Cyclohexanols/pharmacology ; Dose-Response Relationship, Drug ; Humans ; Mitogen-Activated Protein Kinases/drug effects ; Mitogen-Activated Protein Kinases/metabolism ; Morpholines/antagonists & inhibitors ; Naphthalenes/antagonists & inhibitors ; Piperidines/pharmacology ; Pyrazoles/pharmacology ; Receptors, Cannabinoid/physiology ; Reverse Transcriptase Polymerase Chain Reaction/methods ; Signal Transduction/drug effects ; Time Factors ; Trabecular Meshwork/cytology ; Trabecular Meshwork/drug effects ; Type C Phospholipases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
Autorzy:: Thomas A; School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen, UK. />Baillie GL
Phillips AM
Razdan RK
Ross RA
Pertwee RG; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2007 Mar; Vol. 150 (5), pp. 613-23. Date of Electronic Publication: 2007 Jan 22.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Cannabinoid Receptor Agonists*
Anti-Inflammatory Agents/*pharmacology
Benzoxazines/*antagonists & inhibitors
Brain/*drug effects
Cannabidiol/*pharmacology
Cyclohexanes/*antagonists & inhibitors
Morpholines/*antagonists & inhibitors
Naphthalenes/*antagonists & inhibitors
Phenols/*antagonists & inhibitors
Animals ; Anti-Inflammatory Agents/metabolism ; Benzoxazines/pharmacology ; Brain/metabolism ; CHO Cells ; Camphanes/pharmacology ; Cannabidiol/metabolism ; Cannabinoid Receptor Antagonists ; Cell Membrane/drug effects ; Cell Membrane/metabolism ; Cricetinae ; Cricetulus ; Cyclohexanes/pharmacology ; Cyclohexanols ; Dose-Response Relationship, Drug ; Guanosine 5'-O-(3-Thiotriphosphate)/metabolism ; Humans ; In Vitro Techniques ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Morpholines/pharmacology ; Naphthalenes/pharmacology ; Phenols/pharmacology ; Piperidines/pharmacology ; Protein Binding ; Pyrazoles/pharmacology ; Receptor, Cannabinoid, CB1/agonists ; Receptor, Cannabinoid, CB2/agonists ; Receptors, Cannabinoid/genetics ; Receptors, Cannabinoid/metabolism ; Rimonabant ; Transfection

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
Autorzy:: Pertwee RG; School of Medical Sciences, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
Thomas A
Stevenson LA
Ross RA
Varvel SA
Lichtman AH
Martin BR
Razdan RK; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2007 Mar; Vol. 150 (5), pp. 586-94. Date of Electronic Publication: 2007 Jan 22.
Typ publikacji:: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:: Cannabinoid Receptor Antagonists*
Brain/*drug effects
Dronabinol/*analogs & derivatives
Dronabinol/*antagonists & inhibitors
Psychotropic Drugs/*antagonists & inhibitors
Vas Deferens/*drug effects
Analgesics, Non-Narcotic/antagonists & inhibitors ; Animals ; Benzoxazines/pharmacology ; Binding, Competitive ; Body Temperature/drug effects ; Brain/metabolism ; Cannabinoid Receptor Agonists ; Cyclohexanes/metabolism ; Cyclohexanes/pharmacology ; Cyclohexanols ; Dose-Response Relationship, Drug ; Dronabinol/metabolism ; Dronabinol/pharmacology ; Electric Stimulation ; Guanosine 5'-O-(3-Thiotriphosphate)/metabolism ; In Vitro Techniques ; Locomotion/drug effects ; Male ; Mice ; Mice, Inbred ICR ; Morpholines/pharmacology ; Muscle Contraction/drug effects ; Muscle, Smooth/drug effects ; Muscle, Smooth/metabolism ; Naphthalenes/pharmacology ; Pain Measurement ; Pain Threshold/drug effects ; Phenols/metabolism ; Phenols/pharmacology ; Protein Binding ; Receptor, Cannabinoid, CB1/antagonists & inhibitors ; Receptor, Cannabinoid, CB2/antagonists & inhibitors ; Receptors, Cannabinoid/metabolism ; Vas Deferens/metabolism

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Mechanisms of endocannabinoid transport in the brain.
Autorzy:: Kaczocha M; Department of Anesthesiology, Stony Brook University, Stony Brook, New York, USA.; Department of Biochemistry and Cell Biology, Stony Brook University, Stony Brook, New York, USA.
Haj-Dahmane S; Department of Pharmacology and Toxicology, University at Buffalo, Buffalo, New York, USA.; Neuroscience Program, University at Buffalo, Buffalo, New York, USA.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2022 Sep; Vol. 179 (17), pp. 4300-4310. Date of Electronic Publication: 2021 May 27.
Typ publikacji:: Journal Article; Review; Research Support, N.I.H., Extramural
MeSH Terms:: Endocannabinoids*
Synaptic Transmission*
Brain ; Cannabinoid Receptor Modulators ; Receptors, Cannabinoid ; Synapses

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.
Autorzy:: Scherma M; Department of Biomedical Science, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Monserrato (Cagliari), Italy.
Fattore L
Satta V
Businco F
Pigliacampo B
Goldberg SR
Dessi C
Fratta W
Fadda P; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2013 Jun; Vol. 169 (4), pp. 820-33.
Typ publikacji:: Comparative Study; Journal Article; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Disease Models, Animal*
Binge-Eating Disorder/*drug therapy
Cannabinoid Receptor Antagonists/*therapeutic use
Endocannabinoids/*antagonists & inhibitors
Piperidines/*therapeutic use
Pyrazoles/*therapeutic use
Receptor, Cannabinoid, CB1/*antagonists & inhibitors
Signal Transduction/*drug effects
Animals ; Behavior, Animal/drug effects ; Binge-Eating Disorder/chemically induced ; Binge-Eating Disorder/metabolism ; Cannabinoid Receptor Agonists/administration & dosage ; Cannabinoid Receptor Agonists/toxicity ; Cannabinoid Receptor Antagonists/administration & dosage ; Dose-Response Relationship, Drug ; Dronabinol/administration & dosage ; Dronabinol/toxicity ; Drug Inverse Agonism ; Drug Tolerance ; Endocannabinoids/agonists ; Endocannabinoids/metabolism ; Energy Intake/drug effects ; Feeding Behavior/drug effects ; Female ; Margarine/adverse effects ; Piperidines/administration & dosage ; Pyrazoles/administration & dosage ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptor, Cannabinoid, CB1/agonists ; Receptor, Cannabinoid, CB1/metabolism ; Rimonabant ; Weight Loss/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Endocannabinoid tone versus constitutive activity of cannabinoid receptors.
Autorzy:: Howlett AC; Department of Physiology and Pharmacology, Wake Forest University Health Sciences, Winston-Salem, NC 27157, USA. />Reggio PH
Childers SR
Hampson RE
Ulloa NM
Deutsch DG; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2011 Aug; Vol. 163 (7), pp. 1329-43.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Review
MeSH Terms:: Cannabinoid Receptor Agonists*
Endocannabinoids*
Arachidonic Acids/*metabolism
Cannabinoid Receptor Modulators/*metabolism
Glycerides/*metabolism
Polyunsaturated Alkamides/*metabolism
Receptors, Cannabinoid/*metabolism
Animals ; Humans ; Ligands

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Cannabinoid CB 1 /CB 2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.
Autorzy:: Scherma M; Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
Satta V; Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
Collu R; Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.
Boi MF; Department of Internal Medicine, University of Cagliari, Cagliari, Italy.
Usai P; Department of Internal Medicine, University of Cagliari, Cagliari, Italy.
Fratta W; Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.; Centre of Excellence 'Neurobiology of Dependence', University of Cagliari, Cagliari, Italy.
Fadda P; Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, Cagliari, Italy.; Centre of Excellence 'Neurobiology of Dependence', University of Cagliari, Cagliari, Italy.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2017 Aug; Vol. 174 (16), pp. 2682-2695. Date of Electronic Publication: 2017 Jul 11.
Typ publikacji:: Journal Article
MeSH Terms:: Anorexia/*drug therapy
Cannabinoid Receptor Agonists/*therapeutic use
Cyclohexanols/*therapeutic use
Dronabinol/*therapeutic use
Hyperkinesis/*drug therapy
Animals ; Anorexia/blood ; Body Weight/drug effects ; Cannabinoid Receptor Agonists/pharmacology ; Corticosterone/blood ; Cyclohexanols/pharmacology ; Disease Models, Animal ; Dronabinol/pharmacology ; Eating/drug effects ; Female ; Hyperkinesis/blood ; Leptin/blood ; Rats, Sprague-Dawley ; Receptor, Cannabinoid, CB1 ; Receptor, Cannabinoid, CB2 ; Weight Loss/drug effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: The complications of promiscuity: endocannabinoid action and metabolism.
Autorzy:: Alexander SP; School of Biomedical Sciences and Institute of Neuroscience, University of Nottingham Medical School, Nottingham NG7 7LP, UK. />Kendall DA; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2007 Nov; Vol. 152 (5), pp. 602-23. Date of Electronic Publication: 2007 Sep 17.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Endocannabinoids*
Cannabinoid Receptor Modulators/*metabolism
Cannabinoid Receptor Modulators/*pharmacology
Animals ; Cannabinoid Receptor Agonists ; Cannabinoid Receptor Modulators/chemistry ; Humans ; Models, Biological ; Molecular Structure ; Quantitative Structure-Activity Relationship ; Receptors, Cannabinoid/metabolism ; Signal Transduction/drug effects ; Signal Transduction/physiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex.
Autorzy:: Limebeer CL; Department of Psychology and Neuroscience Graduate Program, University of Guelph, Guelph, Ontario, Canada.
Rock EM
Mechoulam R
Parker LA; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2012 Nov; Vol. 167 (5), pp. 1126-36.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antiemetics/*pharmacology
Cannabinoid Receptor Agonists/*pharmacology
Cerebral Cortex/*physiology
Nausea/*drug therapy
Animals ; Cannabinoid Receptor Antagonists/pharmacology ; Cerebral Cortex/drug effects ; Dronabinol/analogs & derivatives ; Dronabinol/pharmacology ; Lithium Chloride ; Male ; Naphthalenes/pharmacology ; Nausea/physiopathology ; Piperidines/pharmacology ; Pyrazoles/pharmacology ; Rats ; Rats, Sprague-Dawley ; Receptor, Cannabinoid, CB1/agonists

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms.
Autorzy:: Maione S; Endocannabinoid Research Group, Section of Pharmacology 'L Donatelli', Department of Experimental Medicine, Second University of Naples, Naples, Italy.
Morera E
Marabese I
Ligresti A
Luongo L
Ortar G
Di Marzo V; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2008 Nov; Vol. 155 (5), pp. 775-82. Date of Electronic Publication: 2008 Jul 28.
Typ publikacji:: Journal Article
MeSH Terms:: Cannabinoid Receptor Antagonists*
Endocannabinoids*
Amidohydrolases/*antagonists & inhibitors
Analgesics/*therapeutic use
Cannabinoid Receptor Modulators/*antagonists & inhibitors
Pain/*drug therapy
Tetrazoles/*therapeutic use
Analgesics/chemistry ; Analgesics/pharmacology ; Animals ; Arachidonic Acids/metabolism ; Dose-Response Relationship, Drug ; Male ; Mice ; Mice, Inbred Strains ; Pain/enzymology ; Pain/metabolism ; Pain Measurement ; Polyunsaturated Alkamides/metabolism ; Structure-Activity Relationship ; Tetrazoles/chemistry ; Tetrazoles/pharmacology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Endocannabinoids and cannabinoid receptors in ischaemia-reperfusion injury and preconditioning.
Autorzy:: Pacher P; Section on Oxidative Stress Tissue Injury, Laboratory of Physiological Studies, NIAAA, National Institutes of Health, Bethesda, MD 20892-9413, USA. />Haskó G; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2008 Jan; Vol. 153 (2), pp. 252-62. Date of Electronic Publication: 2007 Nov 19.
Typ publikacji:: Journal Article; Research Support, N.I.H., Intramural; Review
MeSH Terms:: Endocannabinoids*
Ischemic Preconditioning*
Cannabinoid Receptor Modulators/*physiology
Receptors, Cannabinoid/*physiology
Reperfusion Injury/*drug therapy
Reperfusion Injury/*physiopathology
Animals ; Cannabinoid Receptor Agonists ; Cannabinoid Receptor Modulators/pharmacology ; Cannabinoid Receptor Modulators/therapeutic use ; Humans ; Liver Diseases/drug therapy ; Liver Diseases/physiopathology ; Myocardial Reperfusion Injury/drug therapy ; Shock/drug therapy ; Shock/physiopathology ; Stroke/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain.
Autorzy:: Jhaveri MD; School of Biomedical Sciences, Institute of Neuroscience, Queens Medical Centre, Nottingham, UK. />Richardson D
Chapman V; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2007 Nov; Vol. 152 (5), pp. 624-32. Date of Electronic Publication: 2007 Aug 20.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Endocannabinoids*
Cannabinoid Receptor Modulators/*metabolism
Inflammation/*physiopathology
Pain/*physiopathology
Animals ; Cannabinoid Receptor Antagonists ; Cannabinoid Receptor Modulators/pharmacokinetics ; Humans ; Inflammation/metabolism ; Inflammation/prevention & control ; Models, Biological ; Pain/metabolism ; Pain/prevention & control ; Receptors, Cannabinoid/physiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Emerging roles for endocannabinoids in long-term synaptic plasticity.
Autorzy:: Gerdeman GL; Department of Pharmacology, University of Arizona Health Sciences Center, Tucson, AZ 85724, USA.
Lovinger DM; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2003 Nov; Vol. 140 (5), pp. 781-9. Date of Electronic Publication: 2003 Sep 22.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Endocannabinoids*
Cannabinoid Receptor Modulators/*physiology
Neuronal Plasticity/*physiology
Synapses/*physiology
Animals ; Brain/drug effects ; Brain/physiology ; Cannabinoid Receptor Agonists ; Cannabinoid Receptor Modulators/pharmacology ; Humans ; Neuronal Plasticity/drug effects ; Receptors, Cannabinoid/physiology ; Synapses/drug effects ; Time

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: In vitro determination of the efficacy of illicit synthetic cannabinoids at CB 1 receptors.
Autorzy:: Sachdev S; Department of Biomedical Sciences, Macquarie University, Sydney, NSW, Australia.
Vemuri K; Center for Drug Discovery, Department of Pharmaceutical Sciences and Chemical Biology, Northeastern University, Boston, Massachusetts.
Banister SD; The Lambert Initiative for Cannabinoid Therapeutics, Brain and Mind Centre, The University of Sydney, Sydney, NSW, Australia.; School of Chemistry, The University of Sydney, NSW, Australia.
Longworth M; School of Chemistry, The University of Sydney, NSW, Australia.
Kassiou M; School of Chemistry, The University of Sydney, NSW, Australia.
Santiago M; Department of Biomedical Sciences, Macquarie University, Sydney, NSW, Australia.
Makriyannis A; Center for Drug Discovery, Department of Pharmaceutical Sciences and Chemical Biology, Northeastern University, Boston, Massachusetts.
Connor M; Department of Biomedical Sciences, Macquarie University, Sydney, NSW, Australia.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 Dec; Vol. 176 (24), pp. 4653-4665. Date of Electronic Publication: 2019 Dec 10.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Cannabinoid Receptor Agonists/*pharmacology
Cannabinoid Receptor Antagonists/*pharmacology
Cyclohexanols/*pharmacology
Illicit Drugs/*pharmacology
Receptor, Cannabinoid, CB1/*agonists
Animals ; Cell Line, Tumor ; Dose-Response Relationship, Drug ; Humans ; Mice ; Receptor, Cannabinoid, CB1/antagonists & inhibitors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Opposing roles of CB 1 and CB 2 cannabinoid receptors in the stimulant and rewarding effects of cocaine.
Autorzy:: Gobira PH; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Oliveira AC; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Gomes JS; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
da Silveira VT; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Asth L; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Bastos JR; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Batista EM; Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Issy AC; Department of Morphology, Stomatology and Basic Pathology, Faculty of Odontology, University of São Paulo, Ribeirão Preto, Brazil.
Okine BN; Department of Pharmacology and Therapeutics, School of Medicine, National University of Ireland Galway, Galway, Ireland.
de Oliveira AC; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Ribeiro FM; Department of Biochemistry and Immunology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Del Bel EA; Department of Morphology, Stomatology and Basic Pathology, Faculty of Odontology, University of São Paulo, Ribeirão Preto, Brazil.
Aguiar DC; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.
Finn DP; Department of Pharmacology and Therapeutics, School of Medicine, National University of Ireland Galway, Galway, Ireland.
Moreira FA; Department of Pharmacology, Institute of Biological Sciences, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil.; Pokaż więcej
Źródło:: British journal of pharmacology [Br J Pharmacol] 2019 May; Vol. 176 (10), pp. 1541-1551. Date of Electronic Publication: 2018 Sep 14.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Reward*
Arachidonic Acids/*metabolism
Cocaine/*pharmacology
Endocannabinoids/*metabolism
Glycerides/*metabolism
Polyunsaturated Alkamides/*metabolism
Receptor, Cannabinoid, CB1/*antagonists & inhibitors
Receptor, Cannabinoid, CB2/*agonists
Animals ; Behavior, Animal/drug effects ; Cannabinoid Receptor Agonists/pharmacology ; Cannabinoid Receptor Antagonists/pharmacology ; Conditioning, Classical ; Male ; Mice ; Motor Activity/drug effects ; Protein Binding ; Proto-Oncogene Proteins c-fos/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Fenofibrate Recognition and Gq Protein Coupling Mechanisms of the Human Cannabinoid Receptor CB1
Autorzy:: Tianxin Wang
Wenqin Tang
Ziyi Zhao
Ran Zhao
Zhenyu Lv
Xuzhen Guo
Quanchang Gu
Boxiang Liu
Haoyu Lv
Jiayan Chen
Kaiquan Zhang
Fahui Li
Jiangyun Wang; Pokaż więcej
Temat:: cryo‐electron microscopy
fenofibrate
Gq coupling
human cannabinoid receptor 1
ligand recognition
Science
Źródło:: Advanced Science, Vol 11, Iss 14, Pp n/a-n/a (2024)
Opis pliku:: electronic resource
Relacje:: https://doaj.org/toc/2198-3844
Dostęp URL:: https://doaj.org/article/30365fbeb6904c4dad4d657e84dc1973 Link otwiera się w nowym oknie

Czasopismo naukowe

na półce

Szczegóły

Informacja

Wyszukujesz frazę ""Cannabinoid receptor"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Publikacja

Język